Ergocalciferol and Lamisil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Lamisil (terbinafine hydrochloride). Common drug interactions include anxiety among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Lamisil. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.
What is Ergocalciferol?
Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.
What is Lamisil?
Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.
73 people who take Ergocalciferol and Lamisil together, and have interactions are studied.

What are the common drug interactions of Ergocalciferol and Lamisil, by gender? *:
female:
- Anxiety
- Headache (pain in head)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Back pain
- Contusion (a type of hematoma of tissue in which capillaries)
- Dyspnoea (difficult or laboured respiration)
- Dysuria (painful or difficult urination)
- Fall
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Infection
male:
- Drug ineffective
- Erythema (redness of the skin)
- Skin exfoliation (removal of the oldest dead skin cells)
- Skin lesion
- Skin plaque (red, scaly patches to appear on the skin)
- Transient acantholytic dermatosis (a skin condition that causes the appearance of small, red spots on chest and back)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Injection site reaction
- Gastric ulcer (stomach ulcer)
- Stress
What are the common drug interactions of Ergocalciferol and Lamisil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Acne (skin problems that cause pimples)
- Blood pressure increased
- Fatigue (feeling of tiredness)
40-49:
- Anxiety
- Blood pressure increased
- Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
50-59:
- Drug ineffective
- Body temperature decreased
- Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
- Discomfort
- Erythema (redness of the skin)
- Haemorrhage (bleeding)
- Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin))
- Papule
- Pruritus (severe itching of the skin)
- Skin discolouration (change of skin colour)
60+:
- Anxiety
- Back pain
- Peripheral swelling
- Poor quality sleep
- Renal disorder (kidney disease)
- Sensory disturbance (sense disturbance)
- Skin atrophy (wasting of skin)
- Skin discolouration (change of skin colour)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Weight decreased
What are the existing conditions these people have? *
- Psoriasis (immune-mediated disease that affects the skin): 33 people, 45.21%
- High Blood Pressure: 11 people, 15.07%
- Urticaria (rash of round, red welts on the skin that itch intensely): 9 people, 12.33%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 12.33%
- Pain: 7 people, 9.59%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 6.85%
- Joint Injury: 4 people, 5.48%
* Approximation only. Some reports may have incomplete information.
Do you take Ergocalciferol and Lamisil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ergocalciferol (32,652 reports)
- Lamisil (14,080 reports)
Browse all drug interactions of Ergocalciferol and Lamisil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ergocalciferol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lamisil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ergocalciferol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lamisil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on ergocalciferol and terbinafine hydrochloride (the active ingredients of Ergocalciferol and Lamisil, respectively), and Ergocalciferol and Lamisil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lescol cause Itching? - 3 seconds ago
- Could Estradiol cause Adnexa Uteri Pain? - 5 seconds ago
- Could Propranolol Hydrochloride cause Eye Irritation? - 10 seconds ago
- Drug interactions of Lorazepam and Incruse Ellipta - 23 seconds ago
- Could Zyprexa cause High Blood Cholesterol? - 36 seconds ago
- Could Tagamet cause Hyperkeratosis? - 44 seconds ago
- Could Lipoic Acid cause Rheumatoid Arthritis? - 51 seconds ago
- Could Zide cause Nephropathy Toxic? - 53 seconds ago
- Phenergan and Ibu drug interactions for boys aged 10-19 - 56 seconds ago
- Gastrointestinal Pain and drugs of ingredients of folic acid - 57 seconds ago